相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ADReCS-Target: target profiles for aiding drug safety research and application
Li-Hong Huang et al.
NUCLEIC ACIDS RESEARCH (2018)
Exploration of drug-response mechanism by integrating genetics and epigenetics across cancers
Wenhua Lv et al.
EPIGENOMICS (2018)
PanDrugs: a novel method to prioritize anticancer drug treatments according to individual genomic data
Elena Pineiro-Yanez et al.
GENOME MEDICINE (2018)
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations
David Tamborero et al.
GENOME MEDICINE (2018)
Incorporating methylation genome information improves prediction accuracy for drug treatment responses
Xiaoxuan Xia et al.
BMC GENETICS (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
ADMETNet: The knowledge base of pharmacokinetics and toxicology network
Quan Xu et al.
JOURNAL OF GENETICS AND GENOMICS (2017)
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Sai-Hong Ignatius Ou et al.
LUNG CANCER (2017)
CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer
Malachi Griffith et al.
NATURE GENETICS (2017)
mTCTScan: a comprehensive platform for annotation and prioritization of mutations affecting drug sensitivity in cancers
Mulin Jun Li et al.
NUCLEIC ACIDS RESEARCH (2017)
Characterization of the efficacies of osimertinib and nazartinib against cells expressing clinically relevant epidermal growth factor receptor mutations
Keita Masuzawa et al.
ONCOTARGET (2017)
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Daniele Oddo et al.
CANCER RESEARCH (2016)
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016
Daniel S. W. Tan et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
High-performance web services for querying gene and variant annotation
Jiwen Xin et al.
GENOME BIOLOGY (2016)
Mechanisms of resistance to EGFR-targeted drugs: lung cancer
Floriana Morgillo et al.
ESMO OPEN (2016)
Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapy
David A. Reardon et al.
NEURO-ONCOLOGY (2015)
Predictive value of CHFR and MLH1 methylation in human gastric cancer
Yazhuo Li et al.
GASTRIC CANCER (2015)
Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data
Warren A. Kibbe et al.
NUCLEIC ACIDS RESEARCH (2015)
Reproducibility of Results in Preclinical Studies: A Perspective From the Bone Field
Stavros C. Manolagas et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)
Yuankai Shi et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and New Therapeutic Perspectives in Non Small Cell Lung Cancer
Laura Bonanno et al.
CURRENT DRUG TARGETS (2011)
Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
Parvesh Chaudhry et al.
CANCER INVESTIGATION (2009)
EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer
JY Shih et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
